The prevalence of healthcare-associated infections (HAIs) and the growing elderly population who have impaired immune systems and susceptible to infections are expected to be the major factors driving the portable patient isolation market during the forecast period. Portable patient isolation products are designed and developed for hospitals and other healthcare facilities as an alternative to building fixed and permanent isolation rooms. For instance, products such as ISOQUAD Hospital Bed Isolation Module by Abatement Technologies are likely to have higher traction in Asia, Africa, and the Middle East, where healthcare systems are inadequate.
The implementation of stringent health and safety regulations by government and private bodies around the world also fuels the demand for products such as isolation care solutions. Portable patient isolation products were expected to grow at a rate of around 9% between 2019 and 2020 in pre-COVID-19 projections. However, due to the surge in demand for effective isolation capabilities, the market witnessed a growth rate of 17% between 2019 and 2020 in the post-COVID market. The healthcare segment is the leading segment in terms of growth rate in all regions, with APAC registering the highest CAGR for portable patient isolation products in the healthcare segment.
The surge in COVID-19 cases has escalated the demand for new capacity addition to hospitals. For instance, several governments are developing temporary hospitals to treat COVID-19 patients. Due to this high demand for independent wards, various major and other prominent vendors are strengthening their market presence in these countries to meet the demand for flexible, portable, and scalable isolation capabilities. Hence, it is expected to boost the growth of the portable patient isolation market during the forecast period.
- The portable patient isolation room segment is growing at a promising CAGR during the forecast period and is expected to add an incremental value of $17.25 million.
- APAC is expected to emerge as the fastest-growing segment for room isolation products accounting for a CAGR of 20.65%.
- Europe was the largest pods market in 2020 and is expected to reach over $13 million by 2026.
- The defense and other segments are expected to witness an absolute growth of over 120% due to the impact of the COVID-19 pandemic.
This research report includes a detailed segmentation by-
Hospitals, specialty clinics, and nursing homes are adopting patient isolation systems. It is largely being driven by the rising instances of chronic disease and aging population, which often require assisted care and living. The hospital segment was the largest end-user segment in 2020. Hence, an increase in the capacity of existing hospitals and other medical facilities is expected to proportionally drive the demand for portable patient isolation products. Along with hospitals and clinics, ASC is also expected to witness the adoption of portable patient isolation products worldwide. These centers are cost-effective and offer quality care with a minimal indirect cost of treatment. Most ASCs comply with international standards regarding infections and practice all mandatory guidelines to prevent and control infections. Therefore, this end-user segment is expected to grow at a slower rate than hospitals and clinics during the forecast period.
The pods segment is expected to grow at a CAGR of 11% during the forecast period. The major vendors offering transport pods in the portable patient isolation market are ATA Medical, SiliconCube, Isovac, AirBoss Defense Group, Epiguard, and others. ATA Medical is one of the prominent vendors for transport pods in France. Silicon Cube is a vendor offering transportation pods that are well equipped for emergency transport of virus-infected patients with HEPA filters treated with bacterial enzymes. The global portable patient isolation rooms market is expected to reach USD 30 million by 2026, growing at a CAGR of 16% during the forecast period. Portable units by Gama are designed to create isolation environments for infectious patients under contact or droplet precautions. These rooms help hospitals reduce the spread of bacteria and viruses on their premises.
Europe is the largest market for portable patient isolation systems. The region is expected to witness an absolute growth of 98% from 2020 to 2026. The region will lead the market for instant portable patient isolation products with a CAGR of 12% during the forecast period. The global non-instant portable patient isolation market size is expected to reach USD 23 million by 2026. Alaska Structures and Bioquell are among the key vendors of non-instant portable patient isolation products. Bioquell offers solutions that can provide existing beds with effective isolation capabilities.
North America occupies the second-largest portable patient isolation market share of 33% in 2020. The good prospects of economic growth, the establishment of new healthcare facilities, expansion of healthcare systems, and increased medical construction activities are mainly driving the demand for flexible and scalable patient isolation systems in the region. In the APAC region, the rooms segment is likely to grow at a CAGR of 21% and is generating incremental revenues of over USD 3 million during the forecast period. China was the largest market for portable patient isolation products in APAC, followed by Japan, South Korea, and Australia in 2020. Countries such as China, India, Japan, South Korea, and Australia are building temporary and permanent hospitals for the treatment of COVID-19 affected patients. This is expected to boost the demand for portable patient isolation products in the global market during the forecast period.
The market for portable patient isolation products is fairly distributed with some degree of concentration among the segment of pods and rooms. The global players focus on developing innovative products and expanding their product portfolio to remain competitive in the market. One of the major innovations in the market is the introduction of HEPA filters and air pressure units, capable of containing pathogens, contact, and droplet nuclei, and can generate negative and positive pressures. They invest extensively in R&D and product development activities to expand their product portfolio. The market competition is expected to intensify further with the increase in product/service extensions, growth in technological innovations, and an increase in mergers and acquisitions.
The global portable patient isolation market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Market Segmentation by Product
Market Segmentation by End-user
- Defense & Others
Market Segmentation by Readiness
Market Segmentation by Geography
- North America
- Latin America
- Middle East & Africa